Yan Meng

1.9k total citations
64 papers, 1.2k citations indexed

About

Yan Meng is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Yan Meng has authored 64 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 18 papers in Hepatology and 16 papers in Surgery. Recurrent topics in Yan Meng's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Liver Disease and Transplantation (9 papers). Yan Meng is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Liver Disease and Transplantation (9 papers). Yan Meng collaborates with scholars based in China, United States and Hong Kong. Yan Meng's co-authors include Lixin Wei, Xue Yang, Zhipeng Han, Chen Zong, Fei Ye, Jie Shi, Wan Yee Lau, Yingying Jing, Jinjun Bian and Jing Hou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Hepatology.

In The Last Decade

Yan Meng

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Meng China 21 443 354 304 234 222 64 1.2k
Wenjun Zhang United States 21 477 1.1× 209 0.6× 235 0.8× 332 1.4× 114 0.5× 58 1.2k
K Breitkopf Germany 19 718 1.6× 863 2.4× 545 1.8× 300 1.3× 213 1.0× 28 1.8k
Ningling Kang United States 21 675 1.5× 479 1.4× 331 1.1× 198 0.8× 254 1.1× 32 1.5k
Nadja Lehwald Germany 14 300 0.7× 156 0.4× 213 0.7× 291 1.2× 98 0.4× 45 922
Joan Oliva United States 23 524 1.2× 115 0.3× 244 0.8× 174 0.7× 143 0.6× 55 1.1k
Cong Du China 17 389 0.9× 100 0.3× 128 0.4× 122 0.5× 145 0.7× 28 853
Yujiro Kida Japan 19 671 1.5× 77 0.2× 107 0.4× 174 0.7× 173 0.8× 30 1.4k
Hao Qin China 20 692 1.6× 73 0.2× 294 1.0× 149 0.6× 261 1.2× 60 1.5k
Isabel Huang‐Doran United Kingdom 16 780 1.8× 178 0.5× 341 1.1× 236 1.0× 162 0.7× 23 1.4k
Lin Zhong China 21 632 1.4× 169 0.5× 226 0.7× 247 1.1× 369 1.7× 98 1.4k

Countries citing papers authored by Yan Meng

Since Specialization
Citations

This map shows the geographic impact of Yan Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Meng more than expected).

Fields of papers citing papers by Yan Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Meng. The network helps show where Yan Meng may publish in the future.

Co-authorship network of co-authors of Yan Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Meng. A scholar is included among the top collaborators of Yan Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Meng. Yan Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Zhenkui, Aichang Ji, Yan Meng, et al.. (2025). Establishment of the first marine mollusk cell line from scallop (Chlamys farreri) trochophore. Aquaculture Reports. 40. 102626–102626.
2.
Cheng, Huai‐Yu, et al.. (2025). GNPSum: A code summarization enhancement framework based on Graph Node Position. Information and Software Technology. 187. 107837–107837.
3.
Li, Jing, et al.. (2025). Comparison of clinical characteristics and outcomes in patients with hepatocellular carcinoma based on serum alpha-fetoprotein status. European Journal of Gastroenterology & Hepatology. 37(5). 619–626.
4.
Mayer, Erica L., Mary Lou Smith, Annie Guérin, et al.. (2025). Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2− early breast cancer: a discrete choice survey study. Breast Cancer Research and Treatment. 211(1). 121–130. 1 indexed citations
5.
Schein, Jeff, et al.. (2024). Treatment Preferences of Adult Patients with Attention-Deficit/Hyperactivity Disorder – A Discrete Choice Experiment. Patient Preference and Adherence. Volume 18. 1651–1664. 3 indexed citations
9.
Zhang, Cancan, Yan Meng, Yingying Du, et al.. (2023). Inhibition of γ-glutamyl transferase suppresses airway hyperresponsiveness and airway inflammation in a mouse model of steroid resistant asthma exacerbation. Frontiers in Immunology. 14. 1132939–1132939. 3 indexed citations
10.
Han, Lu, Xin Lin, Qun Yan, et al.. (2022). PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells. Oncogene. 41(13). 1851–1865. 37 indexed citations
11.
Guo, Lei, Xubiao Wei, Shuang Feng, et al.. (2022). Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trial. Hepatology International. 16(6). 1368–1378. 12 indexed citations
12.
Ding, Jian, Yan Meng, Zelong Han, et al.. (2022). Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy. Frontiers in Oncology. 12. 811567–811567. 5 indexed citations
13.
Hou, Xiaojuan, Changchun Shao, Kai Sun, et al.. (2021). Autophagy deficiency downregulates O6methylguanine-DNA methyltransferase and increases chemosensitivity of liver cancer cells. Aging. 13(10). 14289–14303. 3 indexed citations
14.
Chen, Zhenhua, Xiuping Zhang, Shuang Feng, et al.. (2021). Liver resection versus intensity-modulated radiation therapy for treatment of hepatocellular carcinoma with hepatic vein tumor thrombus: a propensity score matching analysis. HepatoBiliary Surgery and Nutrition. 10(5). 646–660. 9 indexed citations
15.
Cheng, Xiaofeng, et al.. (2020). Effectiveness of Metoprolol in Improving Cardiac and Motor Functions in Patients with Chronic Heart Failure: A Prospective Study. SHILAP Revista de lepidopterología.
16.
Yang, Xue, Yan Meng, Zhipeng Han, et al.. (2020). Mesenchymal stem cell therapy for liver disease: full of chances and challenges. Cell & Bioscience. 10(1). 123–123. 80 indexed citations
17.
Jiang, Zhengyu, Lulong Bo, Yan Meng, et al.. (2018). Overexpression of homeodomain-interacting protein kinase 2 (HIPK2) attenuates sepsis-mediated liver injury by restoring autophagy. Cell Death and Disease. 9(9). 847–847. 33 indexed citations
18.
Yao, Ying, Liping Wang, Peipei Jin, et al.. (2017). Methane alleviates carbon tetrachloride induced liver injury in mice: anti-inflammatory action demonstrated by increased PI3K/Akt/GSK-3β-mediated IL-10 expression. Journal of Molecular Histology. 48(4). 301–310. 35 indexed citations
19.
Wang, Kang, Wei Guo, Yi Mao, et al.. (2016). Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus. Medicine. 95(11). e3015–e3015. 89 indexed citations
20.
Gu, Zhifeng, Yan Meng, Tao Tao, et al.. (2015). Endoplasmic reticulum stress participates in the progress of senescence of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Cell and Tissue Research. 361(2). 497–508. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026